vomiting with semaglutide does cause π Semaglutide (Wegovy) β the GLP-1 receptor agonist used for weight management in adults BMI β₯30 or BMI β₯27 with at least one weight-related comorbidity. π©Ί Key points: β’ Delays gastric Nausea and Vomiting on Semaglutide:
Description
doi: 10.1186/1471-2288-14-43

Bressler, C

The primary gallbladder-related concern with GLP-1 receptor agonists relates to cholelithiasis (gallstone formation) and cholecystitis (gallbladder inflammation) in patients who still have their gallbladder

Some patients may experience mild dehydration secondary to the gastrointestinal side effects commonly associated with Rybelsus, particularly nausea, vomiting, and diarrhoea

This change is part of standard benefits for our fully insured group and individual Commercial members

No direct evidence shows that it improves either
